The U.S. Food and Drug Administration on Monday approved a bone-building drug from Pfenex Inc to treat osteoporosis in certain patients at high risk for fractures, giving the company its first commercial product.
Click here for original story, FDA approves Pfenex’s osteoporosis therapy
Source: Reuters Science News